Ramdevbaba Solvent Ltd

Ramdevbaba Sol. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Ramdevbaba Solvent Ltd

₹ 100 -1.95%
03 Jul 10:29 a.m.
Company website NSE - SME: RBS
About

Founded in 2008, Ramdevbaba Solvent Limited produces and distributes physically refined rice bran oil.[1]

Key Points

Business Segments
A) Third Party Manufacturing[1] The Company manufactures, distributes, markets, and sells rice bran oil to FMCG companies like Mother Dairy Fruit & Vegetable Private Limited, Marico Limited, and Empire Spices and Foods Ltd.

Website NSE - SM
  • Market Cap ₹ 222 Cr.
  • Current Price ₹ 100
  • High / Low ₹ 123 / 80.1
  • Stock P/E 17.1
  • Book Value ₹
  • Dividend Yield 0.00 %
  • ROCE 18.6 %
  • ROE 27.2 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 28.1%

Cons

  • Promoter holding has decreased over last quarter: -19.9%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Edible Oil Industry: Solvent Extraction

Edit Columns
Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Sep 2023 Mar 2024
346 295 392
336 283 379
Operating Profit 10 12 13
OPM % 3% 4% 3%
4 2 5
Interest 3 5 5
Depreciation 1 2 2
Profit before tax 10 7 10
Tax % 26% 25% 28%
8 6 8
EPS in Rs 166.99 10.96 4.63
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
105 124 349 424 583 698 686
104 123 337 410 566 679 661
Operating Profit 1 1 12 13 17 19 25
OPM % 1% 1% 3% 3% 3% 3% 4%
0 0 1 2 2 9 7
Interest 0 0 3 4 5 6 10
Depreciation 0 0 3 4 5 2 4
Profit before tax 1 1 6 7 9 19 18
Tax % 0% 0% 19% 19% 22% 24% 26%
1 1 5 6 7 15 13
EPS in Rs 27.64 19.79 110.75 125.57 145.19 320.25 8.04
Dividend Payout % 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 19%
5 Years: %
3 Years: 17%
TTM: -2%
Compounded Profit Growth
10 Years: 34%
5 Years: %
3 Years: 31%
TTM: -11%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 28%
Last Year: 27%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 3 4 5 5 5 16
Reserves 1 3 24 31 43 57
14 12 45 65 99 111
6 9 26 28 44 46
Total Liabilities 24 27 99 129 191 229
14 12 39 40 62 94
CWIP 0 0 0 12 28 3
Investments 0 0 0 0 0 8
10 14 60 77 101 125
Total Assets 24 27 99 129 191 229

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
4 3 -3 3 11 5
-8 -1 -3 -18 -39 -19
3 -2 6 15 28 14
Net Cash Flow 0 1 -0 -0 0 -0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 11 21 16 17 20
Inventory Days 39 26 29
Days Payable 16 16 19
Cash Conversion Cycle 11 21 39 28 31
Working Capital Days 12 12 28 30 30
ROCE % 4% 16% 20%

Shareholding Pattern

Numbers in percentages

6 Recently
Apr 2024
61.09%
5.10%
5.29%
28.52%
No. of Shareholders 1,733

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

No data available.